LakeShore Biopharma Co., Ltd. (NASDAQ:LSB – Get Free Report) shares were down 33% during mid-day trading on Wednesday . The stock traded as low as $0.57 and last traded at $0.53. Approximately 819,833 shares were traded during trading, an increase of 880% from the average daily volume of 83,626 shares. The stock had previously closed at $0.79.
LakeShore Biopharma Trading Down 33.0%
The company has a debt-to-equity ratio of 0.05, a quick ratio of 0.75 and a current ratio of 1.02. The firm has a 50 day moving average price of $0.73 and a 200-day moving average price of $1.10.
About LakeShore Biopharma
LakeShore Biopharma Co, Ltd. engages in the provision of discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People’s Republic of China and Other Countries or Regions.
Read More
- Five stocks we like better than LakeShore Biopharma
- What is diluted earnings per share (Diluted EPS)?
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- 3 REITs to Buy and Hold for the Long Term
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- The Basics of Support and Resistance
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Receive News & Ratings for LakeShore Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LakeShore Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
